What is The Immortal Life of Henrietta Lacks about?

In 1951, a Black woman named Henrietta Lacks died of cervical cancer at Johns Hopkins Hospital. Before she died, a surgeon removed cells from her tumor without her knowledge or consent. Those cells — called HeLa — turned out to be the first human cells that could survive and multiply indefinitely in a lab. They became one of the most important tools in medical history, used in developing the polio vaccine, cancer research, gene mapping, and countless pharmaceutical studies. Henrietta Lacks herself was buried in an unmarked grave. Her family learned about HeLa decades later, largely by accident.

Rebecca Skloot spent nearly a decade reporting this story, weaving together three threads: the science of what HeLa cells made possible, the history of how they were taken and commercialized, and the lives of the Lacks family — particularly Henrietta's daughter Deborah, who became Skloot's guide and the book's emotional center. The result is less a biography than an investigation. Skloot traces how the medical establishment treated Black patients in the Jim Crow South, how informed consent evolved (slowly and incompletely) as a legal and ethical standard, and how the HeLa cell line became a billion-dollar industry whose profits never reached the family whose body it came from.

The book is strongest on the collision between science and personhood. Henrietta Lacks was not a willing donor, a patient who understood what was being taken, or a name that appeared on the papers citing her cells. She was a person reduced to a biological resource. Skloot is careful not to reduce the scientists involved to villains — the norms of the time were what they were — but she does not let those norms off the hook either. The ethical questions the book raises about tissue ownership, consent, and the commercialization of human biology remain unresolved and have grown more pressing with genetic data now routinely collected by hospitals and consumer testing companies.

Skloot writes with the pacing of narrative journalism and the rigor of a science journalist. Some readers find the back-and-forth structure between past and present slows the momentum, and the science sections occasionally outpace the storytelling. But the Deborah chapters carry the book. By the time Skloot and Deborah visit the lab where HeLa cells are still growing, the scene lands with genuine weight. The book does what the best science writing does: it makes an abstract question — who owns the cells in your body? — land as a human story with a specific family, a specific injustice, and no clean ending.